Leaderboards/Ovarian cancer diagnosis and treatment

Ovarian cancer diagnosis and treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Nicole Concin
Innsbruck Medical University
2
Kevin Boehm
Memorial Sloan Kettering Cancer Center
3
Ignacio Vázquez-Garćıa
Uppsala University
4
Marcos A. Fonseca
Cedars-Sinai Medical Center
5
Holly Baker‐Rand
Musgrove Park Hospital
6
Natalia Galant
Medical University of Lublin
7
Wojciech Senkowski
University of Copenhagen
8
Natalia Anna Stańczak
Medical University of Lublin
9
Baoying Liao
Ministry of Education of the People's Republic of China
10
Fine Aliyuda
Medway NHS Foundation Trust

Papers

1
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
The Lancet Oncology|2025
191 cit.
2
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection
International Journal of Molecular Sciences|2024
81 cit.
3
Publication in Annals of Medicine (2024) [76 citations, W4400370050]
Annals of Medicine|2024
76 cit.
4
Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment
Cancers|2024
75 cit.
5
Multimodal histopathologic models stratify hormone receptor-positive early breast cancer
Nature Communications|2025
40 cit.
6
Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients
Cancers|2024
15 cit.
7
Interleukin-22 improves ovulation in polycystic ovary syndrome via STAT3 signaling
Molecular Human Reproduction|2024
5 cit.
8
Application of Fourier transform infrared (FTIR) spectroscopy in liquid biopsy to predict the response to the first-line immunotherapy in non-small-cell lung cancer (NSCLC) patients
Biochemical and Biophysical Research Communications|2025
5 cit.
9
mRNA vaccines in the treatment of cancer
Oncology in Clinical Practice|2024
3 cit.
10
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer—A Study of the GANNET53 Consortium
Clinical Cancer Research|2025
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Gang Ren
Peking University Shougang Hospital
2
Shaili Aggarwal
Drexel University
3
Lenora A. Pluchino
National Comprehensive Cancer Network
4
Wanhai Wang
First Affiliated Hospital of Zhengzhou University
5
Lisa E. Hang
National Comprehensive Cancer Network
6
Robert J. Grumbo
United States Department of the Army
7
Yulia Lakhman
Memorial Sloan Kettering Cancer Center
8
Ellen Stelloo
Cergentis (Netherlands)
9
K Ochiai
Unknown
10
Elizabeth C James
Royal Devon & Exeter NHS Foundation Trust

Papers

1
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
1.7k cit.
2
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2023
545 cit.
3
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2023
520 cit.
4
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
Journal of the National Comprehensive Cancer Network|2022
398 cit.
5
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022
Journal of the National Comprehensive Cancer Network|2022
129 cit.
6
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022
Journal of the National Comprehensive Cancer Network|2022
76 cit.
7
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
PubMed|2022
32 cit.
8
NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022
Journal of the National Comprehensive Cancer Network|2023
19 cit.
9
Synoptic Reporting for Pretreatment CT Examination in Patients With Advanced Ovarian Cancer: Impact on Documentation of Disease Sites and Physician Satisfaction
American Journal of Roentgenology|2023
12 cit.
10
Formalin-Fixed, Paraffin-Embedded–Targeted Locus Capture
Journal of Molecular Diagnostics|2023
6 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Robert E. Scully
Ollscoil na Gaillimhe – University of Galway
2
Ie‐Ming Shih
Johns Hopkins University
3
Robert H. Young
George Washington University Hospital
4
Christopher P. Crum
Brigham and Women's Hospital
5
David M. Gershenson
The University of Texas MD Anderson Cancer Center
6
Andreas du Bois
Kliniken Essen-Mitte
7
David G. Huntsman
BC Cancer Agency
8
Robert C. Bast
The University of Texas MD Anderson Cancer Center
9
Giovanni Scambia
Agostino Gemelli University Polyclinic
10
Douglas F. Easton
University of Cambridge

Papers

1
Genome-wide association study identifies novel breast cancer susceptibility loci
Nature|2007
2.3k cit.
2
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
New England Journal of Medicine|1983
2.2k cit.
3
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
The American Journal of Surgical Pathology|2010
1.8k cit.
4
<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas
New England Journal of Medicine|2010
1.7k cit.
5
Reactivity of a monoclonal antibody with human ovarian carcinoma.
Journal of Clinical Investigation|1981
1.7k cit.
6
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
Cancer|2009
1.6k cit.
7
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
PubMed|1995
1.6k cit.
8
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Journal of Clinical Oncology|2006
1.6k cit.
9
Association analysis identifies 65 new breast cancer risk loci
Nature|2017
1.6k cit.
10
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.
PubMed|1993
1.3k cit.

Reagents for Ovarian cancer diagnosis and treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 62

NONO (E8Q3E) Rabbit Monoclonal Antibody

Cited in 8 papers
#10162$161,351
View Evidence →
Cell Signaling Technology

Phospho-p40phox (Thr154) Antibody

Cited in 7 papers
#4311$362
View Evidence →
Cell Signaling TechnologyEvidence 65

Bim (C34C5) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 7 papers
#94805$465
View Evidence →

🌟 All-Time

Most validated

ProteintechEvidence 64

PAX8 Polyclonal antibody

Cited in 28 papers
#10336-1-AP$449
View Evidence →
Cell Signaling TechnologyEvidence 66

Phospho-4E-BP1 (Thr37/46) (236B4) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 9 papers
#7547$493
View Evidence →
Proteintech

Geminin Polyclonal antibody

Cited in 8 papers
#10802-1-AP$449
View Evidence →